(Q37732612)

22 August 2017

1 reference

title

Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage (English)

1 reference

22 August 2017

Alejandro A. Rabinstein

series ordinal

1

object named as

Alejandro A Rabinstein

1 reference

22 August 2017

2

Giuseppe Lanzino

1 reference

22 August 2017

Eelco Fm Wijdicks

3

1 reference

22 August 2017

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

9

1 reference

22 August 2017

5

1 reference

22 August 2017

504-519

1 reference

Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Sudden death from aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Subarachnoid hemorrhage diagnosis by computed tomography and lumbar puncture: are fifth generation CT scanners better at identifying subarachnoid hemorrhage?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Grading the amount of blood on computed tomograms after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Prediction of angiographic vasospasm after aneurysmal subarachnoid hemorrhage: value of the Hijdra sum scoring system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Timing of computed tomography and prediction of vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Subarachnoid hemorrhage: neurointensive care and aneurysm repair

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Thunderclap headache and normal computed tomographic results: value of cerebrospinal fluid analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Detection of subarachnoid haemorrhage with magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Surgical risk as related to time of intervention in the repair of intracranial aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Medical management of patients with aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Phenytoin and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Nonconvulsive status epilepticus after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Nonconvulsive status epilepticus in patients suffering spontaneous subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Detection of aneurysms by 64-section multidetector CT angiography in patients acutely suspected of having an intracranial aneurysm and comparison with digital subtraction and 3D rotational angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Acute subarachnoid hemorrhage: using 64-slice multidetector CT angiography to "triage" patients' treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

CT angiography with three-dimensional techniques for the early diagnosis of intracranial aneurysms. Comparison with intra-arterial DSA and the surgical findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

A long-term view at clipping versus coiling for ruptured aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the International Subarachnoid Aneurysm Trial (ISAT).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Rates of delayed rebleeding from intracranial aneurysms are low after surgical and endovascular treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

International subarachnoid aneurysm trial of neurosurgical clipping versus endovascular coiling: subgroup analysis of 278 elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the International Subarachnoid Aneurysm Trial?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

1 reference

7 January 2021

Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood flow, brain tissue oxygen, and pH.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Decompressive craniectomy in aneurysmal subarachnoid hemorrhage: relation to cerebral perfusion pressure and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Angiographic and Doppler diagnosis of cerebral artery vasospasm following subarachnoid haemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Transcranial Doppler detection of vertebrobasilar vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Basilar artery vasospasm and delayed posterior circulation ischemia after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Transcranial Doppler grading criteria for basilar artery vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Dynamic perfusion computed tomography in the diagnosis of cerebral vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

CT perfusion predicts secondary cerebral infarction after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Visual grading system for vasospasm based on perfusion CT imaging: comparisons with conventional angiography and quantitative perfusion CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

CT angiography and perfusion imaging in patients with subarachnoid hemorrhage: correlation of vasospasm to perfusion abnormality.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Diagnosing delayed cerebral ischemia with different CT modalities in patients with subarachnoid hemorrhage with clinical deterioration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Vasospasm after subarachnoid hemorrhage: interest in diffusion-weighted MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Diffusion-weighted magnetic resonance imaging in patients with subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Symptomatic vasospasm after subarachnoid haemorrhage: assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Perfusion-weighted magnetic resonance imaging in patients with vasospasm: a useful new tool in the management of patients with subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Perfusion-weighted MRI to evaluate cerebral autoregulation in aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Blood Volume Measurement to Guide Fluid Therapy After Aneurysmal Subarachnoid Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Postoperative hypertension in the management of patients with intracranial arterial aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Cerebral Vasospasm in Subarachnoid Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Increases in Cardiac Output Can Reverse Flow Deficits from Vasospasm Independent of Blood Pressure: A Study Using Xenon Computed Tomographic Measurement of Cerebral Blood Flow

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Pulmonary edema and cardiac dysfunction following subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Myocardial injury and left ventricular performance after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Neurointerventional treatment of vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Fever after subarachnoid hemorrhage: risk factors and impact on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Hyperglycemia after SAH: predictors, associated complications, and impact on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Admission blood glucose levels and early change of neurological grade in poor-grade patients with aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Real-time myocardial perfusion contrast echocardiography and regional wall motion abnormalities after aneurysmal subarachnoid hemorrhage. Clinical article

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Hyponatremia in critically ill neurological patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Risk factors for fever in the neurologic intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Prevention of venous thrombosis in patients with acute intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Pleiotropic effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Statins may not protect against vasospasm in subarachnoid haemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Endothelin and subarachnoid hemorrhage: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Mechanism of endothelin-1-induced contraction in rabbit basilar artery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Endothelin receptor antagonists and cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Hypomagnesemia after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Magnesium: Nature's physiologic calcium blocker

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Microemboli in aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: a 5-year prospective study with review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Lumbar drainage for subarachnoid hemorrhage: technical considerations and safety analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970087-9

7 January 2021

10.1016/S1474-4422(10)70087-9

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20398858